Current Goals

1. Vulnerable plaque detection

• Identify the biologic and imaging characteristics of the high-risk, vulnerable plaque
• Identify individuals at increased risk for the development of high risk plaques who may benefit from early and more aggressive prevention and treatment

2. Pathophysiology of atherosclerosis progression and regression

• Understand the natural history of lesion progression and regression
• Assess the impact of pharmacological treatment
• Correlate biomarkers to the atherosclerotic process by providing state-of-the-art images and technology

3. Translational Research

• Bridging clinical and scientific areas of research to produce new imaging technology, such as multi-center clinical trial administration software.